Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer.
Liu S, Meng X, Chen H, Liu W, Miller T, Murph M, Lu Y, Zhang F, Gagea M, Arteaga CL, Mills GB, Meric-Bernstam F, González-Angulo AM.
Liu S, et al. Among authors: mills gb.
Oncotarget. 2014 Oct 15;5(19):9049-64. doi: 10.18632/oncotarget.2022.
Oncotarget. 2014.
PMID: 24979294
Free PMC article.